Overview
Medullary sponge kidney (MSK), also known as Cacchi-Ricci disease or precalyceal canalicular ectasia, is a congenital malformation of the kidneys characterized by dilation (ectasia) of the collecting tubules in the renal medulla, giving the kidney a sponge-like appearance on imaging. The dilated tubules can be found in one or both kidneys and may affect one or several renal papillae. The condition primarily affects the urinary system and is often discovered incidentally during imaging studies performed for other reasons. Many individuals with medullary sponge kidney remain asymptomatic throughout their lives. However, the dilated collecting ducts predispose to urinary stasis, which can lead to recurrent kidney stones (nephrolithiasis), recurrent urinary tract infections, and hematuria (blood in the urine). Kidney stones, typically composed of calcium oxalate or calcium phosphate, are the most common clinical manifestation and may cause renal colic (flank pain). Some patients also develop nephrocalcinosis (calcium deposits within the kidney tissue). A defect in urinary acidification and hypercalciuria (excess calcium in the urine) are frequently observed metabolic abnormalities. Renal function is generally preserved, though complications from recurrent stones or infections can occasionally lead to impaired kidney function over time. There is no cure for medullary sponge kidney, and treatment is directed at managing symptoms and preventing complications. Management strategies include adequate hydration to reduce stone formation, dietary modifications, and thiazide diuretics or potassium citrate to address hypercalciuria and urinary acidification defects. Urinary tract infections are treated with appropriate antibiotics. Kidney stones may require intervention such as extracorporeal shock wave lithotripsy or ureteroscopy if they cause obstruction or significant symptoms. Regular follow-up with a nephrologist or urologist is recommended to monitor kidney function and manage recurrent stone disease.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsInnovent Biologics (Suzhou) Co. Ltd. — PHASE1
Taichung Veterans General Hospital — EARLY_PHASE1
Qilu Pharmaceutical Co., Ltd. — PHASE3
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. — NA
University College, London — NA
ADARx Pharmaceuticals, Inc. — PHASE2
AbbVie — PHASE3
Instituto Grifols, S.A. — PHASE2
Portsmouth Hospitals NHS Trust — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Medullary sponge kidney.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Medullary sponge kidney at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Medullary sponge kidney.
Community
No community posts yet. Be the first to share your experience with Medullary sponge kidney.
Start the conversation →Latest news about Medullary sponge kidney
Disease timeline:
New recruiting trial: TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Gentamicin Open Tibia Study
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Percutaneous Transcatheter Genicular Embolization in Osteoarthritis
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A new clinical trial is recruiting patients for Medullary sponge kidney
New recruiting trial: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
A new clinical trial is recruiting patients for Medullary sponge kidney
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Medullary sponge kidney
What is Medullary sponge kidney?
Medullary sponge kidney (MSK), also known as Cacchi-Ricci disease or precalyceal canalicular ectasia, is a congenital malformation of the kidneys characterized by dilation (ectasia) of the collecting tubules in the renal medulla, giving the kidney a sponge-like appearance on imaging. The dilated tubules can be found in one or both kidneys and may affect one or several renal papillae. The condition primarily affects the urinary system and is often discovered incidentally during imaging studies performed for other reasons. Many individuals with medullary sponge kidney remain asymptomatic throug
At what age does Medullary sponge kidney typically begin?
Typical onset of Medullary sponge kidney is adult. Age of onset can vary across affected individuals.
Which specialists treat Medullary sponge kidney?
5 specialists and care centers treating Medullary sponge kidney are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.